title: Why did maribavir fail in stem-cell transplants?
authors.affiliation: Division of Geographic Medicine and Infectious Diseases and Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Box 238, 800 Washington Street, Boston, MA 02111, USA. dsnydman@tuftsmedicalcenter.org
authors.forename: David R
authors.initials: DR
authors.lastname: Snydman
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012263:Ribonucleosides / Q000008:administration & dosage*; D033581:Stem Cell Transplantation; D014180:Transplantation; D017211:Treatment Failure; D004004:Dichlororibofuranosylbenzimidazole / Q000031:analogs & derivatives
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D012263:Ribonucleosides; C400401:maribavir; D004004:Dichlororibofuranosylbenzimidazole